Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Established Atherosclerotic Cardiovascular Disease”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableWithdrawnNCT05566678
What this trial is testing

Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic Disease

Who this might be right for
Cardiovascular DiseasesSmokingTobacco Use+2 more
Philip Morris Products S.A.
Large-scale testing (Phase 3)Ended earlyNCT01417104
What this trial is testing

Aliskiren Effect on Aortic Plaque Progression

Who this might be right for
Atherosclerosis
Ohio State University 71
Large-scale testing (Phase 3)Looking for participantsNCT07241390
What this trial is testing

Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

Who this might be right for
Atherosclerosis Cardiovascular DiseaseChronic Kidney Disease
Eli Lilly and Company 7,140
Large-scale testing (Phase 3)Active Not RecruitingNCT05021835
What this trial is testing

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

Who this might be right for
Cardiovascular RiskChronic Kidney DiseaseInflammation
Novo Nordisk A/S 6,200
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Testing effectiveness (Phase 2)Study completedNCT00633022
What this trial is testing

Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

Who this might be right for
Atherosclerosis
GlaxoSmithKline 99
Not applicableLooking for participantsNCT06295679
What this trial is testing

A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

Who this might be right for
Major Cardiovascular EventEstablished Atherosclerotic Cardiovascular Disease
Amgen 7,000
Large-scale testing (Phase 3)Study completedNCT01732822
What this trial is testing

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Who this might be right for
Peripheral Artery Disease
AstraZeneca 13,885
Post-approval studies (Phase 4)Study completedNCT00307307
What this trial is testing

Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

Who this might be right for
Established Carotid Atherosclerosis
University of Pennsylvania 69
Testing effectiveness (Phase 2)Study completedNCT05159219
What this trial is testing

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage

Who this might be right for
Intracranial Hemorrhages
Population Health Research Institute 100
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Large-scale testing (Phase 3)Study completedNCT00382213
What this trial is testing

A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis

Who this might be right for
Atherosclerosis
Daiichi Sankyo 210
Large-scale testing (Phase 3)Study completedNCT06267560
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 422
Large-scale testing (Phase 3)Active Not RecruitingNCT06292013
What this trial is testing

Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company 17,300
Not applicableStudy completedNCT05622929
What this trial is testing

Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control

Who this might be right for
Cardiovascular DiseasesAtherosclerosisDyslipidemias
Hospital Israelita Albert Einstein 1,465
Not applicableStudy completedNCT01942941
What this trial is testing

Peripheral Vascular Disease and Nerve Stimulation

Who this might be right for
Critical Limb IschaemiaClaudicationUlcers+2 more
Hull University Teaching Hospitals NHS Trust 80
Large-scale testing (Phase 3)Looking for participantsNCT06930885
What this trial is testing

Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

Who this might be right for
Atherothrombotic DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)
Hospital do Coracao 7,713
Large-scale testing (Phase 3)Not Yet RecruitingNCT06587737
What this trial is testing

Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

Who this might be right for
ColchicineICH - Intracerebral HemorrhageStroke+1 more
Population Health Research Institute 1,125
Not applicableStudy completedNCT01979471
What this trial is testing

The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH

Who this might be right for
DiabetesChronic Kidney DiseaseEstablished Atherosclerotic Vascular Disease+1 more
University of Alberta 723
Not applicableLooking for participantsNCT06541691
What this trial is testing

Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease

Who this might be right for
Atherosclerotic Cardiovascular DiseaseCoronary Artery DiseaseIschemic Heart Disease+4 more
Rajaie Cardiovascular Medical and Research Center 3,000
Load More Results